Linked Data API

Show Search Form

Search Results

349557
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Wheelchairs: Assessments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many people in England were waiting for a wheelchair assessment in the most recent period for which figures are available; and how many people who have assessed as eligible for a wheelchair since February 2014 have waited (a) more than three, (b) more than six and (c) more than 12 months for the delivery of that equipment. more like this
tabling member constituency Coventry South more like this
tabling member printed
Mr Jim Cunningham more like this
uin 1918 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>Wheelchair services are now commissioned by clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>Whilst the Health and Social Care Information Centre collects data about the health and social care system. The requested information is not collected by it.</p><p> </p> more like this
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
question first answered
less than 2015-06-15T11:57:36.487Zmore like thismore than 2015-06-15T11:57:36.487Z
answering member
1201
label Biography information for Alistair Burt more like this
tabling member
308
label Biography information for Mr Jim Cunningham more like this
349561
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Health and Care Professions Council: Fees and Charges more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what information his Department holds on the reasons for the increase in the mandatory registration fee for membership of the Health and Care Professionals Council; and if he will make a statement. more like this
tabling member constituency Tewkesbury more like this
tabling member printed
Mr Laurence Robertson more like this
uin 1811 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>The Health and Care Professions Council (HCPC) is a self-financing, independent regulator that is accountable to Parliament through the Professional Standards Authority for Health and Social Care (PSA) who assesses the HCPC’s performance, conducts audits, scrutinises their decisions and reports to Parliament.</p><p> </p><p> </p><p> </p><p>It is for the council of the HCPC to set their fees at a level which ensures they can fulfil their statutory role of protecting, promoting and maintaining the health and safety of the public.</p><p> </p><p> </p><p> </p><p>The Department understands that the HCPC publicly consulted on raising their registrant fee and as part of that process explained the raise was for a number of reasons: to fund the periodic fee it is required to pay the PSA; to enable the HCPC to operate more flexibly and efficiently; and to ensure the HCPC’s financial viability in the medium to long term.</p><p> </p> more like this
answering member constituency Ipswich more like this
answering member printed Ben Gummer more like this
question first answered
less than 2015-06-15T14:46:45.967Zmore like thismore than 2015-06-15T14:46:45.967Z
answering member
3988
label Biography information for Ben Gummer more like this
tabling member
253
label Biography information for Mr Laurence Robertson more like this
349621
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Cancer: Immunotherapy more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will take steps to expedite the provision through the NHS of immunotherapy treatments for cancer; and if he will make a statement. more like this
tabling member constituency East Londonderry more like this
tabling member printed
Mr Gregory Campbell more like this
uin 1825 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>A number of immunotherapy drugs are licensed for the treatment of different cancers and are available for use on the National Health Service, subject to funding decisions by the relevant commissioner. Pembrolizumab and nivolumab are two new immunotherapies that are able to treat a number of cancers. The first cancer where these medicines have shown significant increase in patient survival is advanced stage of melanoma. The Medicines and Healthcare products Regulatory Agency has issued early access scientific opinions for both products for treatment of advanced stage melanoma. The Early Access to Medicines scientific opinion for pembrolizumab (Merck Sharp &amp; Dohme) was issued in March 2015 and that for nivolumab (Bristol Myers Squibb) in May 2015.</p><p> </p><p> </p><p> </p><p>Applications for marketing authorisations for both products have already received positive opinions from the European Medicines Agency and marketing authorisations are anticipated to be issued by the European Commission soon.</p><p> </p><p> </p><p> </p><p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) has been able to recommend a number of immunotherapy treatments including, ipilimumab and obinutuzumab. NICE is currently developing technology appraisal guidance on other immunotherapy treatments including nivolumab and pembrolizumab. Wherever possible, NICE aims to publish draft or final guidance on drugs referred to it within a few months of the drug receiving a license. NHS commissioners are legally required to fund drugs and treatments recommended in NICE technology appraisal guidance.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-06-15T13:53:37.777Zmore like thismore than 2015-06-15T13:53:37.777Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1409
label Biography information for Mr Gregory Campbell more like this
349624
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Obesity: Screening more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment NHS England has made of the accuracy and effectiveness of the traditional BMI test in determining levels of obesity in adults. more like this
tabling member constituency East Londonderry more like this
tabling member printed
Mr Gregory Campbell more like this
uin 1828 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>NHS England has not made an independent assessment of the accuracy and effectiveness of Body Mass Index (BMI) in determining overweight and obesity in adults.</p><p> </p><p> </p><p> </p><p>Public Health England and NHS England support the implementation of expert guidance on the use of BMI provided by the National Institute for Health and Care Excellence (NICE). Currently, NICE recommends that BMI is used routinely by healthcare professionals to assess obesity in adults and children.</p><p> </p><p> </p><p> </p><p>NICE recommends the use of additional validated obesity measures, such as waist circumference, to be undertaken alongside BMI when assessing overweight and obesity in individuals to give more detailed assessment of an individual’s health risk.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-06-15T11:31:49.617Zmore like thismore than 2015-06-15T11:31:49.617Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1409
label Biography information for Mr Gregory Campbell more like this
349682
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Rare Diseases more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what estimate he has made of the number of known conditions that meet NHS England's definition of an ultra-rare disease; and how many people in England are known to have been diagnosed with such diseases. more like this
tabling member constituency Leeds North West more like this
tabling member printed
Greg Mulholland more like this
uin 2067 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>In the United Kingdom, the term “ultra-rare disease” is generally used to describe a condition that affects fewer than 500 people, although this is not a formal or legal definition. This equates to a prevalence of about 1 person in 100,000.</p><p> </p><p> </p><p> </p><p>We have been informed by NHS England that no formal estimate has been made of the number of known conditions that meet this definition or those diagnosed. However, the Orphanet directory of rare disease lists about 250 diseases with a prevalence of 1 in 100,000.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 2068 more like this
question first answered
less than 2015-06-15T13:48:43.513Zmore like thismore than 2015-06-15T13:48:43.513Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1540
label Biography information for Greg Mulholland more like this
349683
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Rare Diseases more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what NHS England's definition is of an ultra-rare disease. more like this
tabling member constituency Leeds North West more like this
tabling member printed
Greg Mulholland more like this
uin 2068 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>In the United Kingdom, the term “ultra-rare disease” is generally used to describe a condition that affects fewer than 500 people, although this is not a formal or legal definition. This equates to a prevalence of about 1 person in 100,000.</p><p> </p><p> </p><p> </p><p>We have been informed by NHS England that no formal estimate has been made of the number of known conditions that meet this definition or those diagnosed. However, the Orphanet directory of rare disease lists about 250 diseases with a prevalence of 1 in 100,000.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN 2067 more like this
question first answered
less than 2015-06-15T13:48:43.403Zmore like thismore than 2015-06-15T13:48:43.403Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1540
label Biography information for Greg Mulholland more like this
349685
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading National Institute for Health and Care Excellence: Publications more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, whether it is standard practice for NICE to delay publication of draft guidance for technology appraisals as a result of pre-election purdah. more like this
tabling member constituency Leeds North West more like this
tabling member printed
Greg Mulholland more like this
uin 2071 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>Throughout the pre-election period, the National Institute for Health and Care Excellence (NICE) continued the substantive work on the development of its guidance, including technology appraisals, such as evidence gathering and committee meetings, but postponed publication of draft or final guidance until after the election. This is consistent with the approach that NICE has taken for previous pre-election periods.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2015-06-15T13:50:13.173Zmore like thismore than 2015-06-15T13:50:13.173Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1540
label Biography information for Greg Mulholland more like this
349759
registered interest false more like this
date less than 2015-06-10more like thismore than 2015-06-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Surgery: Buxted more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will discuss with Brighton and Sussex University Hospitals NHS Trust cancellations of intracranial surgical interventions at Buxted Medical Centre. more like this
tabling member constituency Wealden more like this
tabling member printed
Nusrat Ghani more like this
uin 1909 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>This is a matter for the National Health Service.</p><p> </p><p> </p><p> </p><p>We are advised by the NHS Trust Development Authority (TDA) that Brighton and Sussex University Hospitals NHS Trust provides neurosurgery services at the Hurstwood Park Centre at Princess Royal Hospital in Haywards Heath.</p><p> </p><p> </p><p> </p><p>The TDA advises cancellations of elective neurosurgery work may occur at the Trust, particularly when cases require Intensive Care Unit or High Dependency Unit support, as this capacity can at times be taken up with emergency work. The TDA further advises less frequently, emergency procedures themselves may necessitate the postponement of elective work. The TDA is not aware of any issues with cancellations over and above this.</p><p> </p> more like this
answering member constituency Ipswich more like this
answering member printed Ben Gummer more like this
question first answered
less than 2015-06-15T14:42:35.013Zmore like thismore than 2015-06-15T14:42:35.013Z
answering member
3988
label Biography information for Ben Gummer more like this
tabling member
4460
label Biography information for Ms Nusrat Ghani more like this
349163
registered interest false more like this
date less than 2015-06-09more like thismore than 2015-06-09
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Veterans: Social Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps he is taking to ensure that injured military veterans do not have to pay for their social care costs out of their military compensation; and if he will make a statement. more like this
tabling member constituency Tewkesbury more like this
tabling member printed
Mr Laurence Robertson more like this
uin 1548 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>We made a clear commitment, through the Armed Forces Covenant, which we enshrined in legislation in 2011, to support members of the Armed Forces Community, which includes both serving personnel and veterans.</p><p> </p><p> </p><p> </p><p>Social care has never been free and people, including veterans, have always been asked to make a contribution based on what they can afford. Veterans injured before 6 April 2005 receive payments under the War Pensions Scheme, which predates the welfare state. Veterans injured from 6 April 2005 receive payments under the Armed Forces Compensation Scheme. The two schemes reflect the time in which they were developed and as a result they operate differently and are, currently, treated differently in the financial assessment of what people can afford for social care.</p><p> </p><p> </p><p> </p><p>Officials in the Department of Health have been working closely with the Royal British Legion to assess how the two schemes might be treated under the social care charging rules in future and the impact of any change on local authority finances. We are grateful for the time the Royal British Legion has taken to work with the officials. We are very much committed to continuing this conversation.</p><p> </p>
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
question first answered
less than 2015-06-15T11:33:02.14Zmore like thismore than 2015-06-15T11:33:02.14Z
answering member
1201
label Biography information for Alistair Burt more like this
tabling member
253
label Biography information for Mr Laurence Robertson more like this
349313
registered interest false more like this
date less than 2015-06-09more like thismore than 2015-06-09
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health remove filter
hansard heading Health Education England: Personnel Management more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment he has made of Health Education England's workforce planning. more like this
tabling member constituency Scunthorpe more like this
tabling member printed
Nic Dakin more like this
uin 1647 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-06-15more like thismore than 2015-06-15
answer text <p>Health Education England (HEE) has made good progress in creating and implementing a national workforce planning process for the National Health Service and public health system. For the first time, there is now a publication of a national workforce plan for England setting out the investment that will be made in the education and training of the workforce. In developing the plan, HEE has worked closely with local NHS providers, commissioners and other partners to ensure that it reflects the future workforce that is needed to deliver health services.</p><p> </p><p> </p><p> </p><p>HEE has published two workforce plans to date, in December 2013 and most recently in December 2014. The latest plan sets out the education commissions that HEE will make in 2015-16 and forms the basis for future recruitment to postgraduate medical and dental training posts and the contracts with higher education institutions who will deliver the agreed number of education places commencing in September 2015.</p><p> </p><p> </p><p> </p><p>Copies of both documents have been attached.</p><p> </p>
answering member constituency Ipswich more like this
answering member printed Ben Gummer more like this
attachment
1
file name Workforce Plan for England 14-15.pdf more like this
title Health Education England Workforce Plan 2014-15 more like this
2
file name Workforce Plan for England 15-16.pdf more like this
title Health Education England Workforce Plan 2015-16 more like this
question first answered
less than 2015-06-15T11:29:24.987Zmore like thismore than 2015-06-15T11:29:24.987Z
answering member
3988
label Biography information for Ben Gummer more like this
tabling member
4056
label Biography information for Nic Dakin more like this